Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

ProteoGenix launches first Human Immune COVID-19 antibody library

ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.

30 Apr 2020

UHB and Skin Analytics launch new skin cancer community assessment service

University Hospitals Birmingham NHS Foundation Trust and AI specialist Skin Analytics are to pilot a new skin cancer community assessment service to safely reduce delays in skin cancer detection and treatment during the Coronavirus pandemic.

30 Apr 2020

American Lung Association responds to higher rates of COVID-19 impacts among minorities

In response to emerging data showing higher rates of COVID-19 impacts among minorities, American Lung Association President and CEO Harold Wimmer shared the following statement.

30 Apr 2020

New mathematical model precisely estimates the death toll linked to COVID-19

A Rutgers engineer has created a mathematical model that accurately estimates the death toll linked to the COVID-19 pandemic in the United States and could be used around the world.

30 Apr 2020

New review examines the psychological wellbeing of COVID-19 healthcare workers

COVID-19 healthcare workers will be psychologically impacted by their work during the pandemic and will require psychological support from multiple levels in their organisations, according to a review by researchers from Queen Mary University of London, London's Air Ambulance and Barts Health NHS Trust, and a London-based A&E doctor.

30 Apr 2020

Free clinics try to fill gaps as COVID sweeps away job-based insurance

The 55-year-old man, who moved to Tupelo from Georgia to take care of his dying father nearly four years ago, found manufacturing work that came with health insurance.

30 Apr 2020

Fear of coronavirus propels some smokers to quit

In 40 years of smoking, Katie Kennedy has tried four times to quit but always went back to cigarettes. Today, she is summoning a new mental image when a craving comes on: rows of COVID-19 patients hooked to ventilators.

30 Apr 2020

As coronavirus strikes, crucial data in electronic health records hard to harvest

When President Donald Trump started touting hydroxychloroquine as "one of the biggest game changers” for treating COVID-19, researchers hoped electronic health records could quickly tell them if he was on the right track.

30 Apr 2020

LabVantage Solutions announces new purpose-built Biobanking LIMS Accelerator for managing COVID-19 testing

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS that allow labs to go live faster and at a lower total cost, today announced the availability of its new purpose-built COVID-19 LIMS solution.

From LabVantage Solutions 30 Apr 2020

Optimal combinations of protective gears can minimize exposure to chemicals during COVID-19 pandemic

The spread of coronavirus has spurred massive efforts to consistently disinfect everything from office buildings to schools to city buses.

30 Apr 2020

NIH announces new initiative to speed up COVID-19 testing technologies

The National Institutes of Health today announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.

30 Apr 2020

New physiotherapy guidelines to improve long-term physical function and recovery from COVID-19

New physiotherapy guidelines are targeting COVID-19 patient recovery for respiratory management, exercise and mobilisation in acute hospital wards and Intensive Care Units.

30 Apr 2020

Re-establishing pharmaceutical chemical production in Europe in the wake of COVID-19

Over 80% of chemicals used to make pharmaceuticals sold in Europe originate from China or India, according to the European Fine Chemicals Group.

30 Apr 2020

New web-based imaging platform reveals processes in cancer and COVID-19

Medical images for a wide range of diseases, including COVID-19, can now be more easily viewed, compared, and analyzed using a breakthrough web-based imaging platform developed by Massachusetts General Hospital (MGH) and collaborating researchers.

30 Apr 2020

Remdesivir shows powerful activity against SARS-CoV-2 in Vitro

Remdesivir is an antiviral first developed by Gilead in 2014 as a treatment for Ebola and Marburg viruses. However, scientists explored its possibilities as a broad-spectrum drug when it proved effective against SARS-CoV and MERS-CoV, coronaviruses which were responsible for earlier outbreaks.

30 Apr 2020

Study indicates stark disparities in COVID-19-related hospitalizations and deaths in New York

With more than a million confirmed cases of COVID-19 in the United States, there is growing concern that low-income communities and racial/ethnic minorities may be disproportionately shouldering the burden of the pandemic.

30 Apr 2020

A new model for identifying the most effective treatments for respiratory viral infection

When a person contracts a respiratory viral infection like COVID-19 or influenza, the immune system responds in a myriad of ways to eliminate the virus.

29 Apr 2020

Online searches for unproven therapies for COVID-19

A new observational study by a group of scientists explores the rise in the public's fear-driven interest in unproven therapies for COVID-19, particularly chloroquine and hydroxychloroquine, by tracking the internet searches relating to the purchase of drugs in news reports or publicized by public figures. They conclude: "Stay grounded in evidence and fight misinformation." The research letter and accompanying editorial comment are published in the journal JAMA Internal Medicine.

29 Apr 2020

Antibody produced by llamas shows promise against SARS-CoV-2

The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their work: a llama named Winter.

29 Apr 2020

New clinical trial launched to study if convalescent plasma can treat COVID-19

Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma- taken from people who have recovered from COVID-19 - is effective in treating the disease.

29 Apr 2020

Pandemic News and Research

Further Reading

ProteoGenix launches first Human Immune COVID-19 antibody library

UHB and Skin Analytics launch new skin cancer community assessment service

American Lung Association responds to higher rates of COVID-19 impacts among minorities

New mathematical model precisely estimates the death toll linked to COVID-19

New review examines the psychological wellbeing of COVID-19 healthcare workers

Free clinics try to fill gaps as COVID sweeps away job-based insurance

Fear of coronavirus propels some smokers to quit

As coronavirus strikes, crucial data in electronic health records hard to harvest

LabVantage Solutions announces new purpose-built Biobanking LIMS Accelerator for managing COVID-19 testing

Optimal combinations of protective gears can minimize exposure to chemicals during COVID-19 pandemic

NIH announces new initiative to speed up COVID-19 testing technologies

New physiotherapy guidelines to improve long-term physical function and recovery from COVID-19

Re-establishing pharmaceutical chemical production in Europe in the wake of COVID-19

New web-based imaging platform reveals processes in cancer and COVID-19

Remdesivir shows powerful activity against SARS-CoV-2 in Vitro

Study indicates stark disparities in COVID-19-related hospitalizations and deaths in New York

A new model for identifying the most effective treatments for respiratory viral infection

Online searches for unproven therapies for COVID-19

Antibody produced by llamas shows promise against SARS-CoV-2

New clinical trial launched to study if convalescent plasma can treat COVID-19

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News